1. Home
  2. OMER vs HTZ Comparison

OMER vs HTZ Comparison

Compare OMER & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$19.06

Market Cap

844.6M

Sector

Health Care

ML Signal

HOLD

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$2.30

Market Cap

762.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMER
HTZ
Founded
1994
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
844.6M
762.8M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
OMER
HTZ
Price
$19.06
$2.30
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$32.50
$5.67
AVG Volume (30 Days)
2.2M
45.7M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
98.15
73.98
EPS
0.77
N/A
Revenue
$29,868,000.00
$8,504,000,000.00
Revenue This Year
N/A
$4.94
Revenue Next Year
$233.22
$3.62
P/E Ratio
$24.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.94
$1.45
52 Week High
$19.65
$8.18

Technical Indicators

Market Signals
Indicator
OMER
HTZ
Relative Strength Index (RSI) 71.42 50.37
Support Level $18.00 $1.71
Resistance Level $19.65 $2.35
Average True Range (ATR) 0.88 0.16
MACD -0.14 0.03
Stochastic Oscillator 74.55 50.00

Price Performance

Historical Comparison
OMER
HTZ

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

Share on Social Networks: